NovoCure Limited (NASDAQ:NVCR) is expected to report third quarter earnings results, before market open, on Thursday 29th October 2020.
Analysts polled by Thomson Reuters anticipate third quarter income of $ 0.03 per share.
Looking ahead, the full year income are expected at $ 0.15 per share on the revenues of $ 462.31 million.
Previous Quarter Performance
NovoCure Limited disclosed income for the second quarter of $ 0.02 per share, from the revenue of $ 115.92 million. The quarterly revenues grew 44.47 percent compared with the same quarter last year. According to street consensus, revenue of $ 106.03 million was expected for the second quarter The top line results outshined analysts by $ 9.89 million or 9.33 percent.
Stock Performance
Shares of NovoCure Limited traded low $ -4.11 or -3.44 percent on Wednesday, reaching $ 115.39 with volume of 1.08 million shares. NovoCure Limited has traded high as $ 118.06 and has cracked $ 114.28 on the downward trend
According to the previous trading day, closing price of $ 115.39, representing a 123.78 % increase from the 52 week low of $ 53.40 and a 15.18 % decrease over the 52 week high of $ 140.89.
